Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow.
about
Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseasesCell-based therapies of liver diseases: age-related challengesSAMe and HuR in liver physiology: usefulness of stem cells in hepatic differentiation researchAdipose tissue-derived mesenchymal stem cells differentiated into hepatocyte-like cells in vivo and in vitro.Knockdown of the HDAC1 promotes the directed differentiation of bone mesenchymal stem cells into cardiomyocytes.Downregulation of HDAC1 is involved in the cardiomyocyte differentiation from mesenchymal stem cells in a myocardial microenvironment.The multiple functional roles of mesenchymal stem cells in participating in treating liver diseasesBone marrow mesenchymal stem cells differentiate into urothelial cells and the implications for reconstructing urinary bladder mucosa.Isolation of mesenchymal stem cells (MSCs) from green fluorescent protein positive (GFP+) transgenic rodents: the grass is not always green(er)The use of cellular technologies in treatment of liver pathologies.Effect of Chromatin-Remodeling Agents in Hepatic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells In Vitro and In VivoStem cells for liver tissue repair: current knowledge and perspectivesThe epigenetics of adult (somatic) stem cells.In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art.Current status and future prospects of mesenchymal stem cell therapy for liver fibrosisMesenchymal stem cell therapy for nonmusculoskeletal diseases: emerging applications.Current status of stem cell therapy for liver diseases.Induction of hepatocyte-like cells from human umbilical cord-derived mesenchymal stem cells by defined microRNAs.Cell fate conversion: direct induction of hepatocyte-like cells from fibroblasts.Hepatic tissue engineering using scaffolds: state of the artThe role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells.The effect of dimethyl sulfoxide on hepatic differentiation of mesenchymal stem cells.Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells.Efficient programming of human mesenchymal stem cell-derived hepatocytes by epigenetic regulations.Effect of 3D Cultivation Conditions on the Differentiation of Endodermal Cells.Identification of cytokines involved in hepatic differentiation of mBM-MSCs under liver-injury conditions.Differentiation of Bone Marrow: Derived Mesenchymal Stem Cells into Hepatocyte-like Cells.Upregulation of MiR-122 via Trichostatin A Treatments in Hepatocyte-like Cells Derived from Mesenchymal Stem Cells.Trichostatin a promotes cardiomyocyte differentiation of rat mesenchymal stem cells after 5-azacytidine induction or during coculture with neonatal cardiomyocytes via a mechanism independent of histone deacetylase inhibition.Inhibition of the RhoGTPase Cdc42 by ML141 enhances hepatocyte differentiation from human adipose-derived mesenchymal stem cells via the Wnt5a/PI3K/miR-122 pathway: impact of the age of the donor.
P2860
Q26749647-2C1A1D1F-E9CD-4E39-957B-D074E0D1A91FQ26776328-CD0222C7-9919-457F-9D77-5479E8AAC4E2Q26992208-68DF4FC7-58ED-45C6-B171-E8FE3EFCC104Q34731360-2EEDC561-68EF-44F5-A25F-CC55CD318FC2Q35136259-E681988C-F102-4D59-A601-C3F42A8996BEQ35137443-8FCC3E08-71E3-49CA-9C34-BB07CAE989F8Q35206489-640FC754-A4FA-49C8-8DF0-F6D13246B8B4Q35223703-49D64D88-B567-448F-B925-2D21FD700F12Q35296805-ACD8C964-A658-41DE-95CE-5B4F451BCCB0Q36379723-D7B4D62F-07D8-4E22-BCD9-A47A6B1A9ACDQ36924242-617056AF-CEFA-4967-86F5-18654AC26DF7Q37073810-65713698-60BB-4FEF-AE01-9C83DDE42CFFQ37186709-B4B7D267-4CD9-4947-BA38-BB7BAF4AADCAQ37341327-03AED912-9AC8-4BAE-B299-93BCCBC0EF39Q37430773-C6C53EC2-52CF-4B3C-86D1-DFBCC2588197Q37517930-9BF93F3A-B0F1-411E-AF60-FA8DA854E030Q37574218-5D9C2909-1E8D-4151-9B1D-E3EE886B30EFQ37747316-A558E769-B551-4F4B-AC76-C2A41EB9AC03Q38040687-5940EE99-4A71-4E60-89BE-34431C518996Q38081412-D4BC510C-B41F-4F2B-B4C5-4C89E0B746F8Q38727946-7D0A4687-7AB2-4064-9C3D-04181685092BQ38979696-D7E0F75B-DCEF-4ED7-AFAF-829F888370F7Q39806900-E6542569-D130-478B-94F3-18E6D0D09E3AQ40662046-B9EF3E30-CA3A-4AB1-9FB1-1288895F6B9BQ41889116-3814AD0A-5546-48AB-A596-C46DD0B6F93CQ41975016-E89C77A6-44BE-4353-BA06-D15B2D38DA49Q42437161-5E1A09E6-18E2-43C7-A213-9CD748E9743DQ50561949-ED83450C-3661-4703-A300-4A64F11D7FC0Q53217325-F7E2EC45-F907-4C4B-920D-D3ECB24D713BQ55489971-249D0505-C6E6-41F1-BF73-AB172E35844A
P2860
Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Chromatin remodeling agent tri ...... derived of adult bone marrow.
@ast
Chromatin remodeling agent tri ...... derived of adult bone marrow.
@en
type
label
Chromatin remodeling agent tri ...... derived of adult bone marrow.
@ast
Chromatin remodeling agent tri ...... derived of adult bone marrow.
@en
prefLabel
Chromatin remodeling agent tri ...... derived of adult bone marrow.
@ast
Chromatin remodeling agent tri ...... derived of adult bone marrow.
@en
P2093
P2860
P356
P1476
Chromatin remodeling agent tri ...... derived of adult bone marrow.
@en
P2093
Ann De Becker
Ivan Van Riet
Peggy Papeleu
Sarah Snykers
Tamara Vanhaecke
Vera Rogiers
P2860
P2888
P356
10.1186/1471-213X-7-24
P577
2007-04-02T00:00:00Z
P5875
P6179
1045629817